Medical device company AngioDynamics Inc (NASDAQ:ANGO) said on Tuesday that Michael C. Greiner plans to step down as its executive vice president and chief financial officer (CFO).
In conjunction with the change, the company's senior vice president and general counsel Stephen A. Trowbridge will assume the role of interim chief financial officer in addition to his current responsibilities.
However, Greiner will remain with the company to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and has initiated a process to determine a permanent successor.
Additionally, the company is reaffirming its previously issued financial guidance for fiscal year 2020.
Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
ZYLOX Unicorn Vascular Closure Device approved in Indonesia
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software